Search results
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Intrinsic Value Is Potentially 73% Above Its Share...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Regeneron Pharmaceuticals' estimated fair value is US$1,376 based on 2 Stage Free Cash...
Regeneron Bulls, Bears Clash: Will Biotech Get Eylea Mojo Back?
Investor's Business Daily· 8 months agoRegeneron Pharmaceuticals is the IBD Stock of the Day as the biotech giant trades near an all-time...
Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 2 years agoRegeneron (REGN) closed at $587.28 in the latest trading session, marking a +0.2% move from the...
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 7.1% over the past three months, it is easy to disregard Regeneron...
Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 years agoRegeneron (REGN) possesses the right combination of the two key ingredients for a likely earnings...
Regeneron (REGN) Recently Broke Out Above the 20-Day Moving Average
Zacks via Yahoo Finance· 2 years agoRegeneron (REGN) is looking like an interesting pick from a technical perspective, as the company...
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Latest Stock Performance Being Led By Its Strong...
Simply Wall St. via Yahoo Finance· 6 months agoMost readers would already know that Regeneron Pharmaceuticals' (NASDAQ:REGN) stock increased by...
Down -8.24% in 4 Weeks, Here's Why Regeneron (REGN) Looks Ripe for a Turnaround
Zacks via Yahoo Finance· 2 months agoRegeneron (REGN) has become technically an oversold stock now, which implies exhaustion of the heavy...
Regeneron (REGN) Is Up 3.97% in One Week: What You Should Know
Zacks via Yahoo Finance· 5 months agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
Are Strong Financial Prospects The Force That Is Driving The Momentum In Regeneron Pharmaceuticals,...
Simply Wall St. via Yahoo Finance· 9 months agoRegeneron Pharmaceuticals' (NASDAQ:REGN) stock is up by a considerable 19% over the past three...